The need for accurate epidemiology data to drive a higher success rate with Health Technology Assessments

Most drug or device launches today require a health economic valuation often in the form of a Health Technology Assessment (HTA) to satisfy payers that the new ‘technology’ is advantageous for the health system. Most HTAs include epidemiology data in some form. This is often included in order to understand the impact of the technology…

Robust Data Forecasts in the changing healthcare environment

On August 24, 2015, Tags
What’s the issue? The healthcare environment today is not what it used to be. Over the past several decades many pharmaceutical companies have primarily focused on main stream diseases affecting larger populations with unmet clinical needs and limited treatment options. Pharma companies set their sights on discovering blockbuster drugs to address a medical problem for…